Personal Cfo Solutions, LLC Gilead Sciences, Inc. Transaction History

Personal Cfo Solutions, LLC

$704 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $12,025 - $14,664	168 Added 5.7%	3,114 $228,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $364,591 - $413,455	-4,976 Reduced 62.81%	2,946 $238,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $55,381 - $60,421	-749 Reduced 8.64%	7,922 $593,000
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $158,024 - $180,249	-2,079 Reduced 19.34%	8,671 $668,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $27,058 - $30,828	-350 Reduced 3.15%	10,750 $891,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $290,535 - $417,109	4,662 Added 72.41%	11,100 $952,000
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $14,170 - $16,186	238 Added 3.84%	6,438 $397,000
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $21,645 - $24,378	-375 Reduced 5.7%	6,200 $383,000
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $380,824 - $477,213	6,575 New	6,575 $391,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $689,285 - $782,351	-10,624 Closed	0 $0
Q3 2021 Nov 18, 2021	BUY	$67.69 - $73.03 $52,324 - $56,452	773 Added 7.85%	10,624 $742,000
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $69,499 - $75,938	1,095 Added 12.51%	9,851 $678,000
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $240 - $273	4 Added 0.05%	8,756 $566,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $235,097 - $267,882	-4,150 Reduced 32.17%	8,752 $509,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $10,184 - $12,805	-164 Reduced 1.26%	12,902 $1,000
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $21,919 - $25,452	-303 Reduced 2.27%	13,066 $1.01 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $94,320 - $120,811	1,506 Added 12.69%	13,369 $999,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $214,930 - $236,416	-3,488 Reduced 22.72%	11,863 $771,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $959,591 - $1.06 Million	15,351 New	15,351 $1.08 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account